The U.S. Department of Health and Human Services has prioritized expanding access to medication assisted treatment (MAT) for opioid use disorder (OUD) as an evidence-based treatment. Because many individuals with OUD are Medicaid beneficiaries, this U.S. Governmental Accountability Office report looked at state Medicaid policies and state and federal laws that might act as a barrier to Medicaid patients accessing MAT.
This report from the Medicaid and CHIP Payment and Access Commission examines recovery support services to Medicaid beneficiaries with substance use disorders.
This 2019 report to the President and Congress describes how the U.S. Department of Health and Human Services plans to assist states in providing housing-related supports to individuals with substance use disorders in Medicaid as instructed by the 2018 SUPPORT Act. The report describes forthcoming initiatives from
This toolkit by Manatt provides promising strategies state Medicaid agencies can adopt to address the substance use disorder (SUD) and opioid use disorder (OUD) crisis in their states.
In 2019, CMS issued this informational bulletin to state Medicaid directors describing strategies state Medicaid programs could adopt to provide non-opioid and non-medication based treatments for chronic pain.
This report examines how 6 state Medicaid agencies have used data to develop strategies to address the opioid crisis. The report describes how states use data from medical and pharmacy claims, prescription drug monitoring projects (PDMPS), health information exchanges (HIE) and admission, discharge and transfer (ADT) databases to identify providers and patients with problematic opioid-related behaviors and what they do to address these behaviors. Case studies of initiatives in South Dakota, Minnesota and Tennessee are featured.
This 2019 patient/provider decision tool lists alternative pain management therapies that may be considered as an alternative to opioids and whether or not listed treatments are covered by Minnesota Medicaid health plans.
This 2019 report from the Urban Institute analyzed Medicaid State Drug Utilization Data to assess variation in buprenorphine prescriptions across state Medicaid programs between 2011 and 2018.
This 2 pager provides a brief overview of state strategies to implement team-based care for pregnant women eligible for Medicaid from the National Academy for State Health Policy. It also gives a brief overview of strategies adopted in Minnesota, Montana, and the District of Columbia with links for additional information.
This policy brief from the National Academy for State Health Policy reviews Medicaid strategies for identifying and caring for pregnant women with substance use disorders. The report provides a high-level overview of programs operational in 5 states: Connecticut, Florida, Tennessee, Montana, and Vermont.